Vertex Pharma Live Stock Price Today, Share Analysis and Chart

Name: Vertex Pharmaceuticals, Inc.: Is Infosys Ltd. worth buying?
Item: Vertex Pharmaceuticals, Inc.
Rating: 2.191555625
Author: Trendlyne DVM scores

Mid-range Performer

about

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...

491.34 11.16 (2.32%)

Near 52W High of $507.92

8.7M

XNAS Volume

High volume today

XNAS 26 Jun, 2026 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Mid Valuation

43.2 / 100

Technically Neutral

54.4 / 100

Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM

549

1Yr Price target upside is 12%

29 analysts

Vertex Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Vertex Pharma Live Stock Price Today, Share Analysis and Chart

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...

Near 52W High of $507.92

High volume today

SWOT Analysis

Vertex Pharma Live Price Chart